| Literature DB >> 35822187 |
Elahe Samami1, Zohreh Shahhosseini2, Forouzan Elyasi3.
Abstract
Background: Menopause is a normal physiological phenomenon, closely identified with a great deal of physical-psychological symptoms, including hot flashes (HFs) with a prevalence rate of 20-80%. Various pharmacological and non-pharmacological interventions have been thus far practiced to reduce this common symptom of the menopausal transition. Objective: This systematic review was conducted to evaluate the effects of psychological interventions on menopausal HFs. Materials andEntities:
Keywords: Hot flashes; Psychology.; Climacteric; Menopause
Year: 2022 PMID: 35822187 PMCID: PMC9260068 DOI: 10.18502/ijrm.v20i4.10898
Source DB: PubMed Journal: Int J Reprod Biomed ISSN: 2476-3772
Article descriptions
|
| ||||||
|
|
|
|
|
|
|
|
|
| Randomized controlled clinical trial | United States | The effects of SH-CBT on working women with HFs and NS | 45-60 | 124 | HFRS, NSRS, MRQ, SPS, WSAS, WHQ |
|
| Randomized controlled clinical trial | Sweden | The effects of online AR on vasomotor symptoms in postmenopausal women | 47-60 | 46 | HFRDIS |
|
| Quasi-experimental | Spain | The effects of cognitive therapeutic techniques on menopause, depression, and anxiety in Spanish women | 42-55 | 53 | HADS, BKMI |
|
| Randomized controlled clinical trial | United Kingdom | The effects of CBT on vasomotor symptoms (HF and NS) |
| 140 | HFRS, NSRS, GHS-SF-36, WHQ, SSC, SAS, HFBehS |
|
| Quasi-experimental | United Kingdom | The effects of SH-CBT via phone calls on menopause symptoms | 44-77 | 47 | HFRS, HFBS, HFBehs, WHQ |
|
| Quasi-experimental | The effects of CBGT on menopause symptoms | 40-60 | 8 | HFRDIS, GCS, MEN-QOL, MADRS, UQOLS, PSQI, HAS | |
|
| Randomized controlled clinical trial | United States | The effects of hypnotherapy on treatment of HFs in postmenopausal women |
| 187 | PSQI, HFRDIS, HADS, HFSD |
|
| Quasi-experimental | United States | The effects of self-hypnosis on treatment of HFs in postmenopausal women | 46-62 | 13 | HFRDIS |
|
| Randomized controlled clinical trial | Thailand | The effects of AR and MR on treatment of menopausal and premenopausal symptoms | 45-60 | 71 | MRS |
|
| Quasi-experimental | United States | The effects of HRT on HFs in postmenopausal women |
| 62 | HFSD, HFRDIS |
|
| Randomized controlled clinical trial | United Kingdom | The effects of SH-CBT on reducing HFs and NS in postmenopausal women |
| 140 | HFRS, WHQ, HRQOL, GHS-SF-36, SSC |
|
| Clinical trial | Spain | The effects of CBT on women with mild menopausal symptoms | 43-56 | 46 | BKMI, HADS, QOLAQ |
|
| Randomized controlled clinical trial | United States | The effects of MBSR on HFs | 47-69 | 110 | HADS-A, MENQOL, WHIIRS, HF-Intensity |
|
| Quasi-experimental | Iran | The effects of hormone therapy and relaxation techniques on vasomotor disorders in postmenopausal women | - 90 | A self-made demographic questionnaire including 3 sections: Socio-demographic characteristics, medical history, health status and vasomotor disorders | |
|
| Randomized controlled clinical trial | Sweden | The effects of AR on HFs in postmenopausal women | - 102 | BKMI | |
|
| Quasi-experimental | United States | The effects of MBSR on HFs | 47-60 | 15 | MENQOL, Daily HF log, HFRDIS, WHIIRS, SCL-90-R, PSS, Taranto mindfulness scale, Mindfulness practice daily |
|
| Clinical trial | Sweden | The effects of CBT on climacteric syndrome | 42-65 | 30 | MRS, PQ, HADS, MFSQ, VAS |
|
| Randomized controlled clinical trial | Sweden | The effects of AR and estradiol (oral) on treatment of vasomotor symptoms in postmenopausal women | 48-63 | 30 | BKMI, VAS, SCL-90, MOOD-Scale |
|
| Randomized controlled clinical trial | United States | The effects of CBGT on HFs in postmenopausal women | Mean: 51 | 19 | MSQOL, WHQ HFRS |
| SH-stocktickerCBT: Self-help-cognitive behavioral therapy, HFs: Hot flashes, HFRS: Hot flash problem rating scale, NSRS: Night sweat problem rating scale, MRQ: Menopause representations questionnaire, SPS: Stand ford presenteeism scale, WSAS: Work and social adjustment scale, WHQ: Women's health questionnaire, AR: Applied relaxation, HFRDIS: Hot flash related diary interference scale, HADS: Hospital anxiety and depression scale, BKMI: Blatts-Kupperman index, CBT: Cognitive behavioral therapy, HF: Hot flash, NS: Night sweats, GHS-SF-36: General health survey short form-36, SSC: Simplex scientific scale, SAS: Somatic amplification scale, HFBehS: Hot flash behavioral scale, HFBS: Hot flash beliefs scale, CBGT: Cognitive behavioral group therapy, GCS: Green climacterics scale, Men-QOL: Menopause-specific quality of life, MADRS: Montgomery-Asberg depression rating scale, UQOLS: Utian quality of life scale, PSQI: Pittsburg sleep quality inventory, HAS: Hamilton anxiety scale, HFSD: Hot flash symptoms diary, MR: Modified relaxation, MRS: Menopause rating scale, HRT: Hypnotic relaxation therapy, HRQOL: Health related quality of life, QOLAQ: Quality of life assessment questionnaire, MBSR: Mindfulness based stress reduction, HADS-A: Hospital anxiety and depression scale-anxiety, WHIIRS: Women health initiative insomnia rating scale, HF-Intensity: Hot flash intensity, SCL-90-R: Hopkins symptom checklist-90-revise, PSS: Perceived stress scale, PQ: Partnership questionnaire, MFSQ: McCoy female sexuality questionnaire (German translation), VAS: Visual analogue scale | ||||||
The statistical results of the Mann-Whitney U Test, paired and independent-sample t test, Wilcoxon, and repeated measures analysis of included studies
|
|
|
|
|
|
|
|
|
|
| ||
|
| SH-CBT | 4 wk | 6 and 20 wk after intervention | HF problem rating | 6 wk | 0.86-2.11 | < 0.01a | 0.77* | The intervention improved HF problem rating within 6 and 20 wk (S) In addition, the intervention led to a drop in HF frequency within 6 and 20 wk (S) | High risk | |
| 20 wk | 0.31-1.87 | 0.01a | 0.56* | ||||||||
| HF frequency | 6 wk | 4.10-23.91 | 0.01a | 0.39* | |||||||
| 20 wk | 1.05-21.66 | 0.05a | 0.31* | ||||||||
|
| Web-based AR intervention | 9 wk | Before and immediately after intervention | HF frequency | After the intervention | - | 0.09b | - | The intervention had no impact on vasomotor symptoms and HF (NS) | High risk | |
|
| CBT | 8 session (one session per wk) for 2 hr | Before and after intervention | HF symptoms | After the intervention | - | < 0.001a | - | The CBT improved the vasomotor symptoms and decreased HFs (S) | High risk | |
|
| CBT and SH-CBT | 8 session (one session per wk) for 2 hr | 6 and 26 wk after intervention | HF problem rating | CBT | 6 wk | -2.88 to -1.36 | < 0.001a | - | The intervention reduced HF problem rating within 6 and 26 wk (S) SH-CBT intervention decreased HFs within 6 and 26 wk (S) | Low risk |
| 26 wk | -2.13 to -0.54 | < 0.01a | - | ||||||||
| SH-CBT | 6 wk | -2.86 to -1.29 | < 0.001a | - | |||||||
| 26 wk | -2.02 to -0.36 | < 0.01a | - | ||||||||
|
| SH-CBT | 4 wk (one session per wk) for 2 hr and phone counseling (twice a wk) for 15-35 min | Before, 6 wk, and 3 months after intervention | HF problem rating | 6 wk | 48-78 | < 0.001c | - | The intervention improved and decreased the HF problem rating in menopausal women (S) | High risk | |
| 3 months | 54-86 | < 0.001c | - | ||||||||
|
| CBGT | 10 wk (one session per wk) for 2 hr | Before and immediately after intervention | HF symptoms | After intervention | - | 0.01a | - | The CBGT intervention improved and moderated daily HFs (S) | Low risk | |
|
| Hypnotherapy | 5 wk (one session per wk) for 45 min | Before, and 6 and 12 wk after intervention | HF-score | 6 wk | 12.22-16.86 | < 0.001a | - | The hypnotherapy improved and reduced HF-score and HF frequency after intervention and in follow-ups within 6 and 12 wk (S) | Low risk | |
| 12 wk | 12.60-17.54 | < 0.001a | - | ||||||||
| HF frequency | 6 wk | 38.84-47.85 | < 0.001a | - | |||||||
| 12 wk | 36.15-49.67 | < 0.001a | - | ||||||||
|
| Self-hypnosis | 5 wk (one session per wk) for 45 min | Before and immediately after intervention | HF-score | Immediately | 11.8-25.1 | < 0.001c | - | The self-hypnosis intervention reduced HF-score and HF frequency (S) | High risk | |
| HF frequency | Immediately | 52.3-79.53 | < 0.001c | - | |||||||
|
| AR and MR | AR: 12 wk (one session per wk) for 60 min MR: 12 wk (one session per wk) for 60 min and 12 wk of MR home practice (5 sessions per wk) for 15-20 min | Before, 6 wk and 3 months after intervention | HF severity | AR group | 6 wk | - | 0.02d | - | The AR and MR intervention reduced HF severity in women and this downward trend was higher in the MR group compared with the AR one (S) While the intervention decreased HF frequency, the results were not significant (NS) | Low risk |
| 3 months | - | < 0.05d | - | ||||||||
| HF frequency | MR group | 6 wk | - | 0.58d | - | ||||||
| 3 months | - | > 0.05d | - | ||||||||
|
| HRT | 5 wk (one session per wk) for 45 min | Before and after intervention | HF-score | After intervention | - | < 0.01c | - | HRT intervention directly decreased HF score and frequency (S) | Unclear | |
| HF frequency | After intervention | - | < 0.01c | - | |||||||
|
| CBT and SH-CBT | CBT: 4 wk (one session per wk) for 2 hr SH-CBT: Completing a booklet in 4 wk | Before and after intervention | HF problem rating | CBT | 6 wk | -2.88 to -1.36 | < 0.001a | - | The CBT and SH-CBT interventions improved HF problem rating within 6 and 26 wk (S) | Low risk |
| 26 wk | -2.13 to -0.55 | < 0.01a | - | ||||||||
| SH-CBT | 6 wk | -2.09 to -1.29 | < 0.001a | - | |||||||
| 26 wk | -2.02 to -0.36 | 0.01a | - | ||||||||
|
| CBT | 8 wk (one session per wk) for 2 hr | Before and after intervention | HF symptoms | After intervention | - | > 0.05e | - | The CBT intervention did not improve HF symptoms (NS) | High risk | |
|
| MBSR | 8 wk (one session per wk) for 2.5 hr with a session (morning or evening) at the end of the 6 wk | Before, immediately and 12, 16, and 20 wk after intervention | HF intensity | After intervention | 19.8-44.63 | < 0.001a | - | The MBSR reduced HF intensity immediately, 12, 16 and 20 wk after intervention (S) | High risk | |
| 12 and 16 wk | 0.14-24.48 | 0.05a | - | ||||||||
| 20 wk | 31.81-57.31 | < 0.001a | - | ||||||||
|
| Relaxation techniques | 5 daily sessions (every other day) of relaxation and daily practice of relaxation at home for one month | Before, immediately after and one month after intervention | HF frequency | 6 wk | - | < 0.001c | - | The CBT and SH-CBT improved HF problem rating within 6 and 26 wk after intervention (S) | Low risk | |
| One month | - | < 0.001c | - | ||||||||
|
| AR | 12 wk (one session per wk) for 60 min | Before, one, 4, and 12 wk after intervention | HF frequency | 1 wk | -0.6 to 0.1 | < 0.01a | - | The AR reduced daily HF frequency within one, 4, and 12 wk after intervention (S) | Low risk | |
| 4 wk | -1.8 to -0.1 | < 0.01a | - | ||||||||
| 12 wk | -4.1 to -1.5 | < 0.01a | - | ||||||||
|
| MBSR | 8 sessions (7 weekly sessions [one session per wk] for 2.5 hr and one session [morning or evening] at the end of 6 wk) | Before, 7, and 11 wk after intervention | HF severity | 7 wk | - | < 0.001d | - | The MBSR reduced HF severity and frequency within 7 and 11 wk after intervention (S) | Low risk | |
| 11 wk | - | < 0.001d | - | ||||||||
| HF frequency | 7 wk | - | 0.05d | - | |||||||
| 11 wk | - | < 0.001d | - | ||||||||
|
| CBT | 7 wk (one session per wk) for 1.5 hr | Before and immediately after intervention | HF problem rating | After intervention | - | < 0.01e | - | The CBT reduced HF problem rating after intervention (S) | High risk | |
|
| AR | 12 wk (one session per wk) for 60 min | Before, immediately after, 4, 8, and 12 wk, and 3, and 6 months after intervention | HF frequency | After intervention | 4.5-7.6 | < 0.001e | - | The AR decreased HF frequency immediately, 4, 8, and 12 wk, and 3 and 6 months after intervention (S) | High risk | |
| 4 wk | 3.3-6.9 | < 0.001e | - | ||||||||
| 8 wk | 2.5-4.9 | < 0.001e | - | ||||||||
| 12 wk | 2.1-3.9 | < 0.001e | - | ||||||||
| 3 months | 1.0-4.7 | < 0.001e | - | ||||||||
| 6 months | 0.7-2.5 | < 0.001e | - | ||||||||
|
| CBGT | 8 wk (one session per wk) for 90 min | Before and immediately after the intervention | HF problem rating | After intervention | - | < 0.21e | - | The CBGT decreased HF problem rating and frequency, but the results were not significant (NS) | Low risk | |
| HF frequency | After intervention | - | < 0.21e | - | |||||||
|
a |